Corey Kershaw, M.D.

  • Internal Medicine - Pulmonary and Critical Care Medicine
  • Interstitial Lung Disease (Pulmonary Fibrosis)
  • Lung (Pulmonary) Disorders


Corey Kershaw, M.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of its Department of Pulmonary and Critical Care Medicine. He specializes in interstitial lung diseases. In addition, he serves as Medical Director of the Medical Intensive Care Unit and Respiratory Therapy at William P. Clements Jr. University Hospital.

Dr. Kershaw received his medical degree from the University of Texas–Houston. He performed his residency in internal medicine and his fellowship in pulmonary and critical care medicine at Emory University.

Certified by the American Board of Internal Medicine in pulmonary medicine and in critical care medicine, he joined the UT Southwestern faculty in 2010.

Previously, Dr. Kershaw served as an Assistant Professor of Medicine in Emory's Division of Pulmonary, Allergy and Critical Care Medicine, as well as Medical Director of the Atlanta VA Medical Center's Medical Intensive Care Unit.

With his colleagues in the Interstitial Lung Disease Program at UT Southwestern, he participates in IPFnet and industry-funded clinical trials to help find treatments for idiopathic pulmonary fibrosis, as well as other interstitial lung diseases.

Meet Dr. Kershaw

Interstitial Lung Disease Specialist

Corey Kershaw, M.D., an interstitial lung disease (ILD) specialist at UT Southwestern Medical Center, says listening to his patients' stories is a key to correctly diagnosing their disease.

By delving into their history, he's best able to identify which among hundreds of potential ILDs they may have.

"Listening carefully and spending time with our patients helps us figure out why this happened to them, if there is a reason," Dr. Kershaw says.

Dr. Kershaw makes sure his patients understand their disease and what is happening in their lungs. His efforts can help clear up any misconceptions patients may have coming in to their visit. Patients may think they have an untreatable ILD like idiopathic pulmonary fibrosis, only to discover they have a related but treatable disease.

By better educating his patients, Dr. Kershaw helps them find hope and purpose. "It gives them ownership over the disease that they have," he says.

Dr. Kershaw and his colleagues in UT Southwestern's Interstitial Lung Disease Program also help other doctors by providing second opinions. Because there are so many ILDs, it requires expertise and experience to make the correct diagnosis.

"We can sometimes find something that has eluded other doctors," he says.

UT Southwestern's program offers advantages such as access to exclusive clinical trials and tight integration with related services such as lung transplantation and pulmonary rehabilitation, Dr. Kershaw notes.

Dr. Kershaw is also Medical Director of the Medical Intensive Care Unit and Respiratory Therapy at William P. Clements Jr. University Hospital. In this role, he relishes the opportunity to save the lives of people who wouldn't survive if they weren't in the ICU. In addition, he sees patients with other pulmonary problems, including chronic obstructive pulmonary disease (COPD) and asthma.

See More

Education & Training
  • Fellowship - Emory University School of Medicine (2003-2006), Pulmonary Diseases & Critical Care Medicine
  • Residency - Emory University School of Medicine (2000-2003), Internal Medicine
  • Medical School - UT Health Science Center at Houston (1996-2000)
Honors & Awards
  • D Magazine Best Doctor 2020-2022
  • Chief Pulmonary/Critical Care Fellow 2006
Books & Publications

Clinical Focus

  • Interstitial Lung Disease (Pulmonary Fibrosis)
  • Lung (Pulmonary) Disorders
  • Occupational/Environmental Lung Disease

See More

Q&A by Dr. Kershaw

Leaders in Clinical Excellence video: COVID-19 ICU Response Teams